BioSpace News Archive

Smiths Medical, a leading medical device manufacturer, announces our partnership with Bainbridge Health.

Fresenius Kabi Signs Exclusive U.S. Distribution Agreement with Corvida Medical for the HALO ® Closed System Drug-Transfer Device Enhances Fresenius Kabi’s extensive offerings in oncology care

ImmunityBio, Inc. ( NASDAQ: IBRX ), a clinical-stage immunotherapy company, today announced the appointment of health innovation expert and executive Linda Maxwell, M.D., MBA, as an independent member of the company’s board of directors.

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today that it has successfully completed the twelve-months product stability testing required by the U.S. Food and Drug Administration (FDA) for its CypCaps™ final clinical trial product.

Expanded collaboration includes an eight-target discovery partnership leveraging AbCellera’s entire technology stack, including the Trianni Mouse® and the OrthoMab TM bispecific platforms

BIO-CAT Microbials, LLC is pleased to announce receipt of a “Letter of No Objection” from the United States Food and Drug Administration regarding the GRAS (generally regarded as safe) status of its OPTI-BIOME® Bacillus subtilis MB40 microbial ingredient; reference GRN 955 for further details

Bioverge, Inc. (“Bioverge”), an investment platform that funds visionary entrepreneurs who are transforming healthcare and bringing science fiction to life, today announced it has launched an equity crowdfunding platform called Bioverge Portal.

Life Sciences organizations can now turn to the MedPro ComplianceReportingIDTM solution for all their Aggregate Spend reporting needs

Life Sciences organizations can now turn to MedPro Systems for comprehensive compliance guidance and solutions from an in-house team of pharmaceutical and medical device experts

3M Health Information Systems has introduced a new technology platform that allows health care providers and payers to prioritize care and allocate resources for high-risk individuals and patient populations.